2nd Quarter - Report

W STRATEGIES, LLC for GLAXOSMITHKLINE

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.5376: Build Back Better Act including H.R.3: Elijah E. Cummings Lower Drug Costs Now Act, and H.R.19. Lower Costs, More Cures Act of 2021. H.R.1978: Protecting Seniors Through Immunizations Act of 2021.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1978 (117th), H.R. 5376 (117th), H.R. 19 (117th), H.R. 3 (117th)

Health Issues HCR

H.R.7667 - Food and Drug Amendments of 2022, S.4348 - FDASLA Act of 2022. Education around infectious disease therapies as it relates to COVID-19. H.R.7007 - COVID Supplemental Appropriations Act, 2022.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4348 (117th), H.R. 7007 (117th), H.R. 7667 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.